Physician profile
Sara J Roper
NPI 1497198998
$2,249.10
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $91.57 · 2021: $11.65 · 2022: $1,162 · 2023: $358 · 2024: $92.26 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.24 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,149.58 | 2019-2022 | |
| Abbvie INC. | $165.34 | 2019-2023 | Ubrelvy, Lo Loestrin Fe |
| Astellas Pharma US INC | $148.77 | 2023-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $131.14 | 2023-2025 | |
| Organon LLC | $98.92 | 2023-2025 | Nexplanon |
| Lupin INC. | $89.49 | 2019 | |
| Exeltis, USA INC. | $87.26 | 2019-2023 | Slynd, Tyblume |
| Sage Therapeutics, LLC | $83.86 | 2025 | Zurzuvae |
| Cumberland Pharmaceuticals, INC. | $82.02 | 2019-2025 | Caldolor |
| Ethicon US, LLC | $51.65 | 2022-2024 | Enseal X1, Harmonic, Enseal |
| Amag Pharmaceuticals, INC. | $31.96 | 2019 | |
| Duchesnay USA Incorporated | $21.41 | 2019 | |
| Avion Pharmaceuticals | $20.60 | 2019 | |
| Merck Sharp & Dohme LLC | $16.98 | 2020 | |
| Pfizer INC. | $16.34 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.62 | 2019 | |
| Meditrina | $13.76 | 2022 | |
| Boston Scientific Corporation | $12.94 | 2019 | |
| Minerva Surgical, INC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Roper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.